Order results by:
| Issue | Title | |
| Vol 11, No 1 (2019) | Tapering (deprescribing) of benzodiazepine tranquilizers | Abstract similar documents |
| D. A. Sychev, A. V. Zhuchkov, O. V. Tereshchenko, D. V. Ivashchenko | ||
| "... investigations demonstrating the tapering of benzodiazepine tranquilizers: comparison of simple tampering, use ..." | ||
| Vol 6, No 3 (2014) | Alcohol abuse and related disorders treatment of alcohol dependence | Abstract similar documents |
| Yu. P. Sivolap | ||
| "... . Benzodiazepines are the drugs of choice in alleviating alcohol withdrawal and preventing its convulsive attacks ..." | ||
| Vol 16, No 5 (2024) | Gidazepam – daytime tranquilizer for the treatment of anxiety | Abstract similar documents |
| Yu. E. Azimova, D. S. Petelin | ||
| "... Gidazepam is a benzodiazepine tranquilizer with several characteristic pharmacodynamic properties ..." | ||
| Vol 12, No 2 (2020) | Pharmacogenetics of the safety of phenazepam in alcohol withdrawal syndrome: haplotype and combinatorial analyses of polymorphic variants in the pharmacokinetic factor genes | Abstract similar documents |
| D. V. Ivashchenko, O. V. Tereshchenko, I. I. Temirbulatov, K. A. Akmalova, E. A. Grishina, M. S. Zastrozhin, L. M. Savchenko, E. A. Bryun, D. A. Sychev | ||
| "... Phenazepam is a benzodiazepine tranquilizer that is widely used in Russia. The drug is metabolized ..." | ||
| Vol 6, No 4 (2014) | Somatization of anxiety disorders in the practice of a neurologist: Algorithms and approaches to differentiated treatment | Abstract similar documents |
| E. G. Mendelevich | ||
| "... . A number of trials indicate that the use of benzodiazepines (such as phenazepam) may be considered ..." | ||
| Vol 14, No 5 (2022) | Clinical and genetic associations of the CLOCK circadian rhythm gene and depressive disorders in patients with alcohol dependence syndrome during the period of alcohol abstinence | Abstract PDF (Eng) similar documents |
| N. R. Tulbaeva, R. F. Nasyrova, D. A. Smirnova, Z. Sh. Ashurov, I. S. Efremov, V. S. Dobrodeeva, A. E. Abdrakhmanova, A. R. Asadullin | ||
| Vol 15, No 2 (2023) | Withdrawal of valproic acid during pregnancy in women with epilepsy | Abstract similar documents |
| H. I. Navumava, P. N. Vlasov, A. I. Prusakova, A. A. Usoltseva, N. A. Shnayder, D. V. Dmitrenko | ||
| "... Цель исследования – проанализировать особенности течения эпилепсии у женщин после отмены ..." | ||
| Vol 13, No 6 (2021) | Treatment of noncognitive neuropsychiatric disorders in Alzheimer's disease | Abstract similar documents |
| A. B. Lokshina, D. A. Grishina | ||
| Vol 15, No 3 (2023) | Efficacy and safety of a daytime anxiolytic containing technologically processed antibodies to the S100 protein. Overview of clinical studies | Abstract PDF (Eng) similar documents |
| M. Perez, N. N. Zavadenko, L. A. Skipetrova, I. I. Smirnov, Yu. E. Nesterovskiy | ||
| "... in the treatment of anxiety disorders is comparable to that of benzodiazepine drugs. Tenoten has no inhibitory ..." | ||
| Vol 12, No 4 (2020) | Drug-induced headache: an analysis of therapeutic strategies | Abstract similar documents |
| P. A. Merbaum, G. R. Tabeeva, A. V. Sergeev | ||
| "... отмены, факторам риска рецидивов ЛИГБ и способам их предотвращения. ..." | ||
| Vol 8, No 2 (2016) | Effects of etifoxine: Chemoreactome simulation | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. E. Fedotova, A. N. Gromov | ||
| "... compared with the reference drug lorazepam (benzodiazepine). Results and discussion. The data obtained ..." | ||
| Vol 2, No 3 (2010) | Insomnia: clinical experience with Zolpidem (Sanval) | Abstract similar documents |
| Ya. I. Levin | ||
| "... and the minimization of administration of benzodiazepines are most important in pharmacotherapy for insomnia ..." | ||
| Vol 16, No 5 (2024) | Muscle relaxers in acute musculoskeletal back pain | Abstract similar documents |
| A. Kh. Mukhametzyanova, A. I. Isaikin | ||
| "... ) and muscle relaxers (MR). Most modern clinical guidelines recommend non-benzodiazepine MR as the treatment ..." | ||
| Vol 13, No 4 (2021) | Treatment of antipsychotic-induced parkinsonism in schizophrenic patients | Abstract similar documents |
| E. E. Vaiman, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
| "... ; benzodiazepines; herbal preparations traditionally used for the prevention and correction of extrapyramidal ..." | ||
| Vol 12, No 5 (2020) | Drug-induced dystonia | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
| "... (clozapine, quetiapine), benzodiazepines, muscle relaxants (baclofen), and dopamine reuptake inhibitors ..." | ||
| Vol 13, No 1 (2021) | Modern approaches to drug treatment for vestibular vertigo | Abstract similar documents |
| M. V. Zamergrad, S. V. Morozova | ||
| "... (antihistamines, benzodiazepines, and calcium antagonists) and antiemetics (dopamine antagonists and serotonin 5 ..." | ||
| Vol 8, No 4 (2016) | NEUROTROPHIC EFFECTS OF ETIFOXINE | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, V. A. Semenov, O. A. Limanova, I. V. Gogoleva | ||
| "... neurotransmitter receptors than is shown by benzodiazepines. Etifoxine has been also found to have anti ..." | ||
| Vol 9, No 2 (2017) | Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, L. V. Stakhovskaya, L. E. Fedotova | ||
| "... , increase its levels, inhibit benzodiazepine receptor and dopamine reuptake, and enhance neuronal ..." | ||
| Vol 8, No 3 (2016) | Systematic analysis of basic and clinical studies of etifoxine | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, V. A. Semenov, T. R. Grishina | ||
| "... этифоксина. Установлено, что, помимо анксиолитического эффекта, частично сохраняющегося даже после отмены ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Clinical and electroencephalographic polymorphism of malignant migrating partial seizures in infancy | Abstract similar documents |
| A. A. Kholin | ||
| "... is a rational alternative to benzodiazepines in SE in infancy, especially in cases of bulbar innervation ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Long-term levetiracetam monotherapy for partial epilepsy in adults | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, E. G. Komelkova, Z. S. Shakhabasova | ||
| "... + >50% уменьшение частоты припадков) за вычетом процента отмены препарата в результате различных причин ..." | ||
| Vol 15, No 3 (2023) | Cefepime-induced encephalopathy | Abstract similar documents |
| T. N. Pushkar, P. N. Vlasov, A. I. Belyakova-Bodina, A. G. Broutian | ||
| "... его отмены. На электроэнцефалограмме (ЭЭГ) при этом регистрируются генерализованные периодические ..." | ||
| Vol 12, No 1 (2020) | Drug-induced tardive dyskinesia | Abstract similar documents |
| T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
| "... на фоне назначенных пациенту препаратов, мониторирование и коррекция факторов риска ТД, отмена или ..." | ||
| Vol 11, No 2 (2019) | Tobacco smoking dependence in patients with depressive spectrum mental disorders: clinical, pathogenetic, and therapeutic aspects | Abstract similar documents |
| O. I. Speranskaya, S. A. Trushchelev, Z. I. Storozheva | ||
| "... немедикаментозных методов. Это позволяет добиться плавной редукции синдрома отмены табакокурения и избежать ..." | ||
| Vol 4, No 4 (2012) | Clinical social and neurobiological aspects of the assesment of social danger of patients with schizophrenia and organic mental disorders | Abstract similar documents |
| Andrey Yurjevich Berezantsev, D A Kuznetsov | ||
| "... дополнительными критериями для назначения и отмены принудительного лечения у данной категории лиц и позволяют ..." | ||
| Vol 2, No 2 (2010) | Clinical electroencephalographic criteria for the efficacy of rispolept therapy in children with Tourette's syndrome | Abstract similar documents |
| V. P. Zykov, S. A. Kabanova | ||
| "... , побочные эффекты отмечались редко и не требовали отмены препарата. ..." | ||
| Vol 10, No 2 (2018) | CLIPPERS syndrome | Abstract similar documents |
| T. E. Schmidt, I. N. Pronin, K. Yu. Kazantsev, O. N. Voskresenskaya, I. V. Damulin, A. A. Aleksandrov, N. N. Yakhno | ||
| "... терапию ГК и ее отмену. Приведены данные литературы и диагностические критерии этого заболевания. ..." | ||
| Vol 16, No 4 (2024) | Ten rules for oral anticoagulants prescription after a stroke | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, D. A. Demin, S. S. Kucherenko | ||
| "... ; развитие инсульта на фоне приема антикоагулянта; сроки отмены и возобновления терапии при хирургических ..." | ||
| Vol 13, No 2 (2021) | Drug-induced hypersomnia | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, O. D. Ostroumova, A. V. Filippova, T. F. Guseva | ||
| "... заболеваний, а также развиваться при злоупотреблении и/или отмене различных лекарственных средств (ЛС ..." | ||
| Vol 13, No 1 (2021) | Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva, V. A. Parfenov, G. R. Tabeeva, D. V. Romanov, V. V. Osipova, Z. Katsarava | ||
| "... трудности при их отмене, неудовлетворительная переносимость профилактической фармакотерапии мигрени. С ..." | ||
| Vol 12, No 6 (2020) | Use of akatinol memantine for the treatment of Korsakoff's syndrome: a clinical case | Abstract similar documents |
| N. A. Tyuvina, T. N. Maksimova, S. V. Prokhorova, V. O. Vysokova | ||
| "... высвобождение которого из связи с NMDA-рецепторами происходит в период отмены этанола. В последнее время для ..." | ||
| Vol 4, No 1 (2012) | Sleep disorders in mental diseases and their correction | Abstract similar documents |
| Nina Arkadyevna Tyuvina, E P Shchukina, E A Izotova | ||
| "... формирования зависимости и синдрома отмены позволяет использовать санвал длительными курсами, особенно у ..." | ||
| Vol 4, No 2 (2012) | The efficacy and tolerability of paroxetine (adepress), an antidepressant from a group of selective serotonin reuptake inhibitors, in psychoautonomic syndrome within anxiety-depressive disorders | Abstract similar documents |
| T G Voznesenskaya, N M Fokina | ||
| "... эффектов не превышала 3 баллов. Они не требовали ни коррекции дозы, ни отмены препарата и проходили ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Comparative analysis of the efficacy of different treatment strategies in medication overuse headache: an open-label prospective trial | Abstract similar documents |
| A. V. Sergeev, E. A. Guziy, N. A. Kovalchuk, E. A. Sokolov, G. V. Grigoriev, G. R. Tabeeva | ||
| "... программ отмены абузусного препарата и курса детоксикации. Материал и методы. В исследование включено 44 ..." | ||
| Vol 13, No 6 (2021) | Drug-induced parkinsonism | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, O. D. Ostroumova, A. S. Soloveva | ||
| "... лечения ЛИП является снижение дозы препарата-индуктора, или его отмена, или замена на другой препарат. У ..." | ||
| Vol 12, No 3 (2020) | Drug-induced cognitive impairment | Abstract similar documents |
| O. D. Ostroumova, M. I. Kulikova, T. M. Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, V. A. Parfenov | ||
| "... когнитивных функций и началом приема препарата. Лечение таких КН предполагает прежде всего отмену или снижение ..." | ||
| Vol 12, No 4 (2020) | Depressions with eating disorders: clinical manifestations and therapy | Abstract similar documents |
| V. E. Medvedev, V. I. Frolova, E. V. Gushanskaya, Yu. S. Fofanova, S. E. Martynov, N. L. Zuikova, A. M. Burno, S. V. Nekrasova, I. V. Salyntsev | ||
| "... характер и/или не выражены, не требуют отмены терапии. Заключение. Агомелатин является эффективным и ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Analysis of the clinical experience with perampanel in the Moscow Region: Efficacy, tolerability, individual choice priorities | Abstract similar documents |
| I. G. Rudakova, Yu. A. Belova | ||
| "... , связанными с отменой ПЕР. ПЕР является эффективным инструментом в преодолении фармакорезистентности при ..." | ||
| Vol 7, No 2 (2015) | Neuromuscular disorders in chronic alcohol intoxication | Abstract similar documents |
| A. Yu. Emelyanova, O. E. Zinovyeva, N. D. Samkhaeva, N. S. Shcheglova | ||
| "... невропатии, помимо отмены алкоголя и восстановления сбалансированного питания, рассматривается ..." | ||
| Vol 2, No 3 (2010) | Use of depakine chronosphere as a first monotherapy to treat epilepsy in children | Abstract similar documents |
| E. D. Belousova, A. Yu. Ermakov | ||
| "... была хорошей. Нежелательные явления отмечены у 7,41% пациентов и послужили поводом для отмены препарата ..." | ||
| Vol 5, No 1 (2013) | Dopamine dysregulation syndrome in Parkinson’s disease | Abstract similar documents |
| A V Nikitina, Natalia Vladimirovna Fedorova | ||
| "... агонистов дофаминергических рецепторов с последующей отменой препарата. ..." | ||
| Vol 12, No 3 (2020) | Heterogeneity of myelopathy in patients with systemic sarcoidosis | Abstract similar documents |
| V. S. Krasnov, V. V. Zuykova, E. V. Bubnova, O. P. Baranova, A. A. Skoromets | ||
| "... положительной динамикой после отмены глюкокортикоидов. Заключение. Необходимо учитывать возможность наличия ..." | ||
| Vol 13, No 1 (2021) | Role of pathogenetic therapy for diabetic polyneuropathy | Abstract similar documents |
| D. A. Iskra, V. V. Kovalchuk, E. R. Barantsevich | ||
| "... случае не было выявлено нежелательных реакций и не возникло необходимости в отмене данного препарата. На ..." | ||
| Vol 12, No 2 (2020) | Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome | Abstract similar documents |
| V. E. Medvedev, R. A. Kardashyan, V. I. Frolova, A. M. Burno, S. V. Nekrasova, V. I. Salyntsev | ||
| "... заменой антидепрессанта. Во 2-й группе (n=35) милнаципран назначали с постепенной (2 нед) отменой ..." | ||
| Vol 11, No 1 (2019) | Efficiency of long-term vinpocetine administration in the treatment of dizziness and associated statodynamic disorders in patients with chronic cerebrovascular insufficiency (EDELWEISS study) | Abstract similar documents |
| I. N. Samartsev, S. A. Zhivolupov, Yu. S. Butakova, M. V. Morozova, I. N. Barsukov | ||
| "... наблюдения после ее отмены). Результаты и обсуждение. Применение винпоцетина значимо снизило субъективную ..." | ||
| Vol 5, No 1S (2013): Special issue "Epilepsy" | Efficiency and tolerance of sustained-release valproate sodium (Depakine®ChronosphereТМ) as the drug of the first choice in the treatment of adult epilepsy | Abstract similar documents |
| E. D. Belousova, G. N. Avakyan | ||
| "... Хроносфера была хорошей. Нежелательные явления отмечались у 15,7% пациентов, но служили поводом для отмены ..." | ||
| Vol 2, No 3 (2010) | Russian observational study of the efficacy and tolerability of depakine chrono as first-line monotherapy for focal epilepsy | Abstract similar documents |
| E. D. Belousova | ||
| "... выраженности и привели к отмене препарата только у 10 (0,6%) из 1580 пациентов. Наиболее частыми побочными ..." | ||
| Vol 16, No 3 (2024) | Analyzing the predictors of relapse in drug-induced headache: a prospective clinical and psychological study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... беседу, «детоксикационную» и симптоматическую терапию периода отмены с одновременным назначением курса ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... терапии оценивали по частоте развития нежелательных явлений и их тяжести, частоте отмены препарата ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Evaluation of the efficacy of preventive therapy in chronic migraine with or without medication overuse headache: data from a prospective study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... «детоксикационной» терапии и отменой / ограничением использования абузусного препарата у всех пациентов с ХМ и ЛИГБ ..." | ||
| Vol 13, No 3 (2021) | Depression treatment in women and men with bipolar affective disorder: a comparative study | Abstract similar documents |
| N. A. Tyuvina, A. E. Stolyarova, V. V. Balabanova, K. M. Bunkova, E. N. Efremova | ||
| "... динамического наблюдения за пациентом в целях своевременной отмены препарата и снижения риска инверсии фазы и ..." | ||
| Vol 1, No 3-4 (2009) | RUSSIAN OBSERVATIONAL SURVEY OF THE SHORT-TERM EFFICACY AND TOLERABILITY OF SUSTAINED-RELEASE SODIUM VALPROATE (DEPAKINE CHRONOSPHERA®) AS A FIRST-LINE DRUG IN THE TREATMENT OF EPILEPSY | Abstract similar documents |
| E. D. Belousova, A. Yu. Ermakov | ||
| "... детей эффективно и безопасно. Низкий уровень отмены препарата свидетельствует о его хорошей ..." | ||
| Vol 3, No 2 (2011) | Therapy of depression in patients with focal epilepsy: experience with citalopram use | Abstract similar documents |
| A. V. Lebedeva, E. G. Melikyan, A. B. Gekht | ||
| "... требовали отмены препарата. ..." | ||
| Vol 15, No 4 (2023) | Experience with agomelatine therapy for non-psychotic depression with a single and recurrent course | Abstract similar documents |
| L. A. Ivanova, A. V. Kovaleva, N. O. Sitnikova | ||
| "... ,9%), они были легко выраженными и не потребовали отмены препарата. Из исследования выбыли два пациента ..." | ||
| Vol 16, No 3 (2024) | Observational study of the effect of perampanel on sleep and daytime sleepiness in adult patients with epilepsy in real-life clinical practice | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, M. A. Vagina, A. V. Vasilenko, T. M. Goguadze, T. V. Danilova, O. N. Kirillovskikh, I. Yu. Kovaleva, Yu. A. Kornukova, S. Yu. Lavrik, I. V. Larina, L. V. Lipatova, E. R. Tokareva, A. V. Ulitin, N. V. Filatova, M. A. Yamin | ||
| "... . Результаты. К 12 мес наблюдения показатель удержания на комплексной терапии с ПЕР составил 84,9%. Отмена ПЕР ..." | ||
| Vol 15, No 5 (2023) | Efficacy and safety of Vespireit® (buspirone) prolonged-release tablets (PR) 15 mg in the therapy of patients with functional dizziness: results of the double-blind, placebo-controlled, multicenter, randomized, phase 3 clinical trial | Abstract similar documents |
| M. V. Zamergrad, V. A. Parfenov, A. S. Agafina, N. V. Lyamina, M. M. Gavrik, L. R. Kuchumova, E. R. Barantsevich, V. S. Krasnov, A. A. Ivanova, A. L. Vladykin, K. А. Ishchenko | ||
| "... тяжести ≥3, с серьезными НЯ (СНЯ), с СНЯ с летальным исходом, с НЯ, приведшими к отмене исследуемой ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... натализумаба более 2 лет. Вероятно, возобновление активности РС после отмены натализумаба является достаточно ..." | ||
| 1 - 57 of 57 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
